tiprankstipranks
Innovotech Secures European Patent for Antimicrobial Silver Compounds
Company Announcements

Innovotech Secures European Patent for Antimicrobial Silver Compounds

Story Highlights

Stay Ahead of the Market:

The latest update is out from Innovotech ( (TSE:IOT) ).

Innovotech Inc. announced that its invention involving antimicrobial silver compounds, specifically InnovoSIL™-1 silver, has been granted a European patent. This patent covers the use of these compounds in medical devices, offering broad-spectrum activity against bacterial and fungal biofilms and providing a potential solution to antibiotic resistance. The patent opens opportunities for Innovotech to license these applications to European industry partners, enhancing their products with antiplanktonic, antiviral, anti-adherence, or antibiofilm properties.

More about Innovotech

Innovotech Inc. is a Canadian biotechnology company that owns proprietary intellectual property, conducts contract research, and provides proprietary devices for testing various applications in microbiology.

YTD Price Performance: 0.0%

Average Trading Volume: 14,976

Technical Sentiment Consensus Rating: Strong Sell

Current Market Cap: C$8.95M

See more insights into IOT stock on TipRanks’ Stock Analysis page.

Related Articles
TipRanks Canadian Auto-Generated NewsdeskInnovotech Reports Record Revenue Growth
TipRanks Canadian Auto-Generated NewsdeskInnovotech Expands with Keystone Labs Acquisition
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App